A study on the significance of probiotic treatment for type 2 diabetes patients with periodontal disease
Not Applicable
- Conditions
- Type2 diabetes mellitus and periodontal disease
- Registration Number
- JPRN-UMIN000032553
- Lead Sponsor
- ational Hospital Organization Kagoshima Medical Center
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 20
Inclusion Criteria
Not provided
Exclusion Criteria
Patients currently receiving periodontal disease treatment. Patients who changed or increased oral hypoglycemic drugs within the past 3 month. Women who are pregnant or breast feeding. Patients who received diagnosis of malignant tumor within the past year. Patients who developed cardiovascular events within the past year.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Improvement of Both HbA1c or glycoalbumin and periodontal disease.
- Secondary Outcome Measures
Name Time Method Improvement of TNF-alfa Improvement of malondialdehyde (MDA) Improvement of total antioxidant capacity (TAC)